BIOMAT Database Logo BIOMAT Database Logo

Phenotypic changes in mouse leukemia L1210 cells with alterations in the effector-binding subunit of ribonucleotide reductase. 2000

J G Cory, and L Somerville, and A W He, and A H Cory
Department of Biochemistry, East Carolina University School of Medicine, Greenville, NC 27858-4354, USA.

UI MeSH Term Description Entries
D007939 Leukemia L1210 An experimental LYMPHOCYTIC LEUKEMIA of mice. Leukemia L 1210,L 1210, Leukemia,L1210, Leukemia
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D012264 Ribonucleotide Reductases Ribonucleotide Reductase,Reductase, Ribonucleotide,Reductases, Ribonucleotide
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

J G Cory, and L Somerville, and A W He, and A H Cory
Ribonucleotide reductase activity and growth of glutathione-depleted mouse leukemia L1210 cells in vitro.
June 1988, Cancer letters,
J G Cory, and L Somerville, and A W He, and A H Cory
Differential turnover of the subunits of ribonucleotide reductase in synchronized leukemia L1210 cells.
December 1986, Cancer research,
J G Cory, and L Somerville, and A W He, and A H Cory
Cross-talk between the allosteric effector-binding sites in mouse ribonucleotide reductase.
October 2000, The Journal of biological chemistry,
J G Cory, and L Somerville, and A W He, and A H Cory
Leukemia L1210 cell lines resistant to ribonucleotide reductase inhibitors.
February 1988, Cancer research,
J G Cory, and L Somerville, and A W He, and A H Cory
Changes in messenger RNA levels for the subunits of ribonucleotide reductase during the cell cycle of leukemia L1210 cells.
January 1989, Cancer communications,
J G Cory, and L Somerville, and A W He, and A H Cory
Characterization of mouse leukemia L1210 cells resistant to the ribonucleotide reductase inhibitor 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone.
January 1996, Oncology research,
J G Cory, and L Somerville, and A W He, and A H Cory
Inhibition of ribonucleotide reductase, DNA synthesis, and L1210 leukemia by guanazole.
September 1970, Cancer research,
J G Cory, and L Somerville, and A W He, and A H Cory
Cell-cycle associated transcriptional regulation of ribonucleotide reductase in L1210 leukemia cells and drug-resistant variants.
January 1991, Cancer communications,
J G Cory, and L Somerville, and A W He, and A H Cory
Inhibition of ribonucleotide reductase by gallium in murine leukemic L1210 cells.
November 1991, Cancer research,
J G Cory, and L Somerville, and A W He, and A H Cory
Inhibition of ribonucleotide reductase and growth of human colon carcinoma HT-29 cells and mouse leukemia L1210 cells by N-hydroxy-N'-aminoguanidine derivatives.
October 1990, Biochemical pharmacology,
Copied contents to your clipboard!